ASTRO 2020: Investigational Relugolix an Effective Alternative to Traditional Androgen Deprivation Therapy for Advanced Prostate Cancer, With or Without Radiotherapy
This oral therapy has not yet attained FDA approval
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.